Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Apple Shares Face Analyst Skepticism Following iPhone 17 Unveiling

Robert Sasse by Robert Sasse
September 15, 2025
in Analysis, Earnings, Nasdaq, Tech & Software
0
Apple Stock
0
SHARES
151
VIEWS
Share on FacebookShare on Twitter

Wall Street analysts delivered a notably tepid response to Apple’s September 9th product launch event, with several firms downgrading their outlook on the tech giant’s stock. The newly unveiled iPhone 17 lineup, including an ultra-thin iPhone Air model and updated Pro versions, failed to generate the anticipated enthusiasm among market experts, raising questions about Apple’s innovation trajectory.

Downgrades and Diminishing Confidence

Within days of the keynote presentation, DA Davidson removed its buy recommendation for Apple shares. The firm characterized the new offerings as “uninspired,” citing a lack of compelling reasons for consumers to upgrade their devices. This assessment was followed by even more bearish moves from other analysts.

Phillip Securities took a more aggressive stance by downgrading Apple to “Reduce” with a $200 price target. Analyst Helena Wang highlighted multiple headwinds facing the company, including tariff pressures, rising investment costs, and—most significantly—weakening sales performance in the critical Chinese market. According to industry tracking by MacDailyNews, analyst sentiment toward Apple has reached its lowest point in five years, marking a dramatic shift for a company long regarded as a technology innovation leader.

Incremental Improvements Fall Short

The iPhone Air, measuring a record-thin 5.6 millimeters, was positioned as the centerpiece of Apple’s presentation. Alongside the new iPhone 17 models, the upgraded A19 Pro chip, and enhanced camera systems, the company demonstrated solid technological progression across its product range.

However, this evolutionary approach proved precisely the problem. While Morgan Stanley acknowledged the “truly differentiated” design of the iPhone Air, the firm simultaneously noted that more substantial updates likely wouldn’t arrive until 2026. HSBC analysts pointed out that Apple Intelligence features “still haven’t delivered on their 2024 promises,” with only the AirPods Pro 3’s live translation capabilities generating notable interest—insufficient to drive significant sales momentum.

Should investors sell immediately? Or is it worth buying Apple?

Artificial Intelligence Delays Compound Concerns

Adding to Apple’s challenges, the highly anticipated Siri overhaul faced another postponement, now scheduled for 2026. This delay places Apple at an increasing competitive disadvantage as rivals including Google and Microsoft continue to aggressively expand their AI capabilities.

The company’s position in artificial intelligence development was further weakened by the departure of several key personnel. Ruoming Pang, Mark Lee, and Tom Gunter—all significant contributors to Apple’s AI initiatives—reportedly left to join Meta, exacerbating concerns about the company’s ability to compete in this critical technological domain.

Performance Lags Behind Tech Peers

Apple’s stock performance reflects this growing market skepticism. With a decline exceeding 6% since the beginning of the year, the company currently trails behind other members of the “Magnificent 7” tech stocks. Analyst consensus suggests minimal upside potential, with average price targets of $240 representing just 3% appreciation from current levels.

Some market observers maintain cautious optimism looking toward 2026. Morgan Stanley anticipates “the most significant Apple Intelligence update” potentially arriving that year, possibly through partnerships with Google, OpenAI, or Anthropic. Citi analysts have speculated about a foldable iPhone model that might stimulate a stronger upgrade cycle. The central question remains whether Apple can maintain investor confidence until these potential catalysts materialize.

Ad

Apple Stock: Buy or Sell?! New Apple Analysis from March 25 delivers the answer:

The latest Apple figures speak for themselves: Urgent action needed for Apple investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Apple: Buy or sell? Read more here...

Tags: Apple
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock
AI & Quantum Computing

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
Next Post
XPeng Stock

XPeng Faces Major Setback as Steering Defect Prompts Large-Scale Vehicle Recall

C3.ai Stock

Leadership Turmoil and Withdrawn Guidance Plague C3.ai

Alibaba Stock

Alibaba's Strategic Pivot: Major AI Breakthrough and $3.2 Billion Funding Initiative

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com